Larvol Delta - PureTech-Presents-New-Phase-2b-Analyses-Demonstrating-Consistent-Safety-and-Efcacy-of-Deupirfenidone-in-Older-Patients-with-Idiopathic-Pulmonary-Fibrosis-IPF-a-Historically-Undertreated-Group

deupirfenidone (LYT-100) - PureTech

https://www.businesswire.com/news/home/20251021394027/en/PureTech-Presents-New-Phase-2b-Analyses-Demonstrating-Consistent-Safety-and-Efficacy-of-Deupirfenidone-in-Older-Patients-with-Idiopathic-Pulmonary-Fibrosis-IPF-a-Historically-Undertreated-Group

Oct 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next